Golden Biotechnology Corp. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 91.282 million compared to TWD 104.002 million a year ago. Operating loss was TWD 334.566 million compared to TWD 312.723 million a year ago. Net loss was TWD 343.770 million compared to TWD 326.894 million a year ago. Basic loss per share was TWD 3.06 compared to TWD 2.98 a year ago.